A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: Safety, efficacy, visual morbidity, and outcomes

BACKGROUND: Bevacizumab is increasingly used in children with pediatric low-grade glioma (PLGG) despite limited evidence. A nationwide UK service evaluation was conducted to provide larger cohort “real life” safety and efficacy data including functional visual outcomes. METHODS: Children receiving b...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Katherine, Panagopoulou, Paraskevi, D’Arco, Felice, O’Hare, Patricia, Bowman, Richard, Walters, Bronwen, Dahl, Christine, Jorgensen, Mette, Patel, Pritesh, Slater, Olga, Ahmed, Rehana, Bailey, Simon, Carceller, Fernando, Collins, Rhiannon, Corley, Elizabeth, English, Martin, Howells, Lisa, Kamal, Ahmed, Kilday, John-Paul (JP), Lowis, Stephen, Lumb, Blanche, Pace, Erika, Picton, Susan, Pizer, Barry, Shafiq, Ayad, Uzunova, Lena, Wayman, Harriet, Wilson, Shaun, Hargrave, Darren, Opocher, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Pediatric Neuro-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076941/
https://www.ncbi.nlm.nih.gov/pubmed/36239316
http://dx.doi.org/10.1093/neuonc/noac223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076941/
https://www.ncbi.nlm.nih.gov/pubmed/36239316
http://dx.doi.org/10.1093/neuonc/noac223

Ejemplares similares